Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Novo Nordisk’s type two diabetes treatment for adults approved in japan
March 23, 2018 Off

Novo Nordisk’s type two diabetes treatment for adults approved in japan

By Dino Mustafić

The Japanese Ministry of Health, Labour and Welfare has approved Novo Nordisk’s treatment for type 2 diabetes adult patients, new…

First Japanese company joins CARB-X partnership in the fight against drug resistant bacteria
March 22, 2018 Off

First Japanese company joins CARB-X partnership in the fight against drug resistant bacteria

By Dino Mustafić

CARB-X is partnering with Shionogi of Osaka, Japan, to support the development of a novel β-lactam antibiotic with potent activity…

NIH: Immune cells in the retina can spontaneously regenerate
March 22, 2018 Off

NIH: Immune cells in the retina can spontaneously regenerate

By Dino Mustafić

Immune cells called microglia can completely repopulate themselves in the retina after being nearly eliminated, according to a new study…

Weight Changes In Seniors: Possible Causes And Treatments
March 22, 2018 Off

Weight Changes In Seniors: Possible Causes And Treatments

By Dino Mustafić

As we grow older we are faced with an increased number of health conditions that can not only be very…

FDA: 5 Things to Know About Breast Implants
March 21, 2018 Off

FDA: 5 Things to Know About Breast Implants

By Dino Mustafić

Should I get breast implants? Are there alternatives? Will they need to be replaced? And if I decide to get…

Sobi launches Ravicti in Europe and advances the care for patients with Urea Cycle Disorders
March 21, 2018 Off

Sobi launches Ravicti in Europe and advances the care for patients with Urea Cycle Disorders

By Dino Mustafić

Swedish Orphan Biovitrum has gained reimbursement for Ravicti, a new therapy option for the treatment of patients with Urea Cycle…

Fifth FDA-approved indication for Adcetris changes four decades old way to treat Hodgkin lymphoma
March 20, 2018 Off

Fifth FDA-approved indication for Adcetris changes four decades old way to treat Hodgkin lymphoma

By Dino Mustafić

The U.S. Food and Drug Administration on Tuesday approved Saettle Genetics’s Adcetris (brentuximab vedotin) to treat adult patients with previously…

Mylan launches Mitomycin, generic cancer drug version of BMS’s Mutamycin
March 20, 2018 Off

Mylan launches Mitomycin, generic cancer drug version of BMS’s Mutamycin

By Dino Mustafić

Mylan N.V. has launched its generic version of BMSs oncology drug Mutamycin in USA, called Mitomycin, for which it noted…

Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies
March 20, 2018 Off

Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies

By Dino Mustafić

Novartis has teamed up with scientists from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber…

Hikma launches Ritonavir Tablets USP
March 20, 2018 Off

Hikma launches Ritonavir Tablets USP

By Dino Mustafić

Hikma Pharmaceuticals’s wholly owned US subsidiary West-Ward Pharmaceuticals, has launched Ritonavir Tablets USP, 100 mg, the first AB-rated generic to…

Posts pagination

Previous 1 … 3,395 3,396 3,397 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine